Company intelligence / Profile preview

ECHAS

Charlottesville, Virginia, USAmassgeneralbrigham.org ↗

Ownership: Private
Development stage: Other

Overview

The ECHAS app demonstrated high sensitivity—98% accuracy in identifying patients needing emergency evaluation for heart attack or stroke symptoms. In an initial clinical study with 202 emergency room patients, it correctly identified all cases requiring hospital admission. The average assessment time was under two minutes for stroke and about one minute for heart attack. The app was rated highly usable by participants. However, specificity was low (~8%), meaning some unnecessary referrals may occur; further real-world studies are planned before broad release.

Therapeutic areas: Cardiovascular
Modalities: DeviceNon-pharmacological therapy (digital triage tool)
Industry: Digital Health Medical Devices

Partnerships

UVA Health SystemHarvard UniversityNortheastern UniversityCenter for Telehealth at UVA

Beyond the preview

Go deeper on ECHAS.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ECHAS.

Explore the full profile